Dublin, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The "Cell Line Development and Characterization Services by Sources of Cell Lines/Expression Systems, Applications of Cell Lines, and Geography: Industry ...
In addition, the chapter includes information on additional cell line related services (bio-analytical / protein purification, cell banking, cell bank characterization, process development, GMP ...
Global Cell Line Development Services Market Value to near USD 12,957.8 Million by 2033 FMI Analysis
The demand for cell line development services is anticipated to grow at an average year-on-year growth rate of 7.4% during the years from 2023 to 2033. The new market analysis report by FMI estimates ...
The demand for cell line development services market is set to surge, with an anticipated valuation of USD 6,365.2 million in 2023, projected to grow at a robust compound annual growth rate (CAGR) of ...
LONDON, Jan. 11, 2024 /PRNewswire/ -- According to a recently published report by Roots Analysis, the growing demand for biologics to treat biologics and increasing research activities for cell line ...
Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / ...
The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / Expression System, Application of Cell Line, ...
Biopharmaceutical manufacturers must consider a surprisingly wide range of factors when deciding where to turn for assistance with cell line development. Biopharmaceuticals are revolutionizing the way ...
ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company’s proprietary Leap-In Transposase® genome engineering tools.
According to SNS Insider, the global Cell Line Development Market was valued at USD 5.46 billion in 2023 and is projected to reach USD 12.56 billion by 2032, expanding at a CAGR of 9.66% from ...
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine ® platform has been selected by FairJourney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results